-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Oruka Therapeutics, Raises Price Target to $63

Benzinga·11/13/2025 10:08:06
Listen to the news
BTIG analyst Julian Harrison maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and raises the price target from $56 to $63.